Surrogate outcomes in quality-of-life research: where will we end up?

J Clin Oncol. 2003 May 1;21(9):1894-5; author reply 1895. doi: 10.1200/JCO.2003.99.244.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials as Topic*
  • Endpoint Determination*
  • Health Status
  • Humans
  • Neoplasms / psychology*
  • Neoplasms / therapy*
  • Quality of Life*
  • Research Design